Specifications - VaxGen Biopharmaceutical Manufacturing Plant, San Francisco, California, USA

Key Data
Order year	February 2002
Project type	New Plant
Location	South San Francisco, California, USA
Estimated investment	$11m
Completion	June 2003 on-stream
Key Players
Sponsor	VaxGen, Nexol Corp, KT&G, J Stephen and Co Ventures Ltd, Celltrion Inc
Lead engineer / designer	Fluor Enterprises Inc
Validation	Fluor Enterprises Inc, VaxGen QA
Financing	Nexol Corp, KT&G, J Stephen and Co Ventures Ltd
Output Chemicals
Type	Vaccines, protein therapeutics and monoclonal antibodies
Featured Suppliers
Applikon Biotechnology - Bioreactor Systems